Alongside’s Eli Lilly LLY Stock Holding History

Alongside’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	+1,561	New	+$1.59M	0.36%	56
2025 Q4	$1.69M	Buy	+1,574	New	+$1.51M	0.56%	29

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alongside's LLY Position: Q2 2026 in Review

Alongside opened a new position in Eli Lilly (LLY) in Q2 2026: 1,561 shares worth $1.87M. The stake represents 0.36% of the portfolio and ranks #56 among its holdings. This is a return to the name: Alongside previously reported a position in LLY as recently as Q4 2025.

Alongside first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Alongside held 1,561 shares of Eli Lilly worth $1.87M as of Q2 2026.
Eli Lilly was a new Alongside position in Q2 2026.
Eli Lilly made up 0.36% of Alongside's portfolio in Q2 2026, its #56 holding.
Alongside first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alongside's 13F filing for Q2 2026, filed 14 Aug 2026.